BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33723056)

  • 21. PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas.
    Yang B; Hu P; Lin X; Han W; Zhu L; Tan X; Ye F; Wang G; Wu F; Yin B; Bao Z; Jiang T; Yuan J; Qiang B; Peng X
    Cell Mol Life Sci; 2015 Nov; 72(22):4383-97. PubMed ID: 26047657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Disease-Associated Mutations on the Deaminase Activity of ADAR1.
    Karki A; Campbell KB; Mozumder S; Fisher AJ; Beal PA
    Biochemistry; 2024 Feb; 63(3):282-293. PubMed ID: 38190734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.
    Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM
    Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions.
    Hood JL; Morabito MV; Martinez CR; Gilbert JA; Ferrick EA; Ayers GD; Chappell JD; Dermody TS; Emeson RB
    Mol Cell Neurosci; 2014 Jul; 61():97-109. PubMed ID: 24906008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered A-to-I RNA editing in human embryogenesis.
    Shtrichman R; Germanguz I; Mandel R; Ziskind A; Nahor I; Safran M; Osenberg S; Sherf O; Rechavi G; Itskovitz-Eldor J
    PLoS One; 2012; 7(7):e41576. PubMed ID: 22859999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
    Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
    Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dyschromatosis symmetrica hereditaria: A clue to early diagnosis of Aicardi-Goutières syndrome.
    Ahmed F; Do N; Vanderver AL; Treat JR
    Pediatr Dermatol; 2024; 41(1):156-157. PubMed ID: 37770123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
    Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
    Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing.
    George CX; Wagner MV; Samuel CE
    J Biol Chem; 2005 Apr; 280(15):15020-8. PubMed ID: 15677478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Aicardi-Goutières Syndrome-Causative Point Mutation in
    Inoue M; Nakahama T; Yamasaki R; Shibuya T; Kim JI; Todo H; Xing Y; Kato Y; Morii E; Kawahara Y
    J Immunol; 2021 Dec; 207(12):3016-3027. PubMed ID: 34772697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.
    Rice GI; Kasher PR; Forte GM; Mannion NM; Greenwood SM; Szynkiewicz M; Dickerson JE; Bhaskar SS; Zampini M; Briggs TA; Jenkinson EM; Bacino CA; Battini R; Bertini E; Brogan PA; Brueton LA; Carpanelli M; De Laet C; de Lonlay P; del Toro M; Desguerre I; Fazzi E; Garcia-Cazorla A; Heiberg A; Kawaguchi M; Kumar R; Lin JP; Lourenco CM; Male AM; Marques W; Mignot C; Olivieri I; Orcesi S; Prabhakar P; Rasmussen M; Robinson RA; Rozenberg F; Schmidt JL; Steindl K; Tan TY; van der Merwe WG; Vanderver A; Vassallo G; Wakeling EL; Wassmer E; Whittaker E; Livingston JH; Lebon P; Suzuki T; McLaughlin PJ; Keegan LP; O'Connell MA; Lovell SC; Crow YJ
    Nat Genet; 2012 Nov; 44(11):1243-8. PubMed ID: 23001123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The p150 Isoform of ADAR1 Blocks Sustained RLR signaling and Apoptosis during Influenza Virus Infection.
    Vogel OA; Han J; Liang CY; Manicassamy S; Perez JT; Manicassamy B
    PLoS Pathog; 2020 Sep; 16(9):e1008842. PubMed ID: 32898178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation.
    Yang JH; Nie Y; Zhao Q; Su Y; Pypaert M; Su H; Rabinovici R
    J Biol Chem; 2003 Nov; 278(46):45833-42. PubMed ID: 12954622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral striatal necrosis and dyschromatosis symmetrica hereditaria: A-I editing efficiency of ADAR1 mutants and phenotype expression.
    Kono M; Suganuma M; Dutta A; Ghosh SK; Takeichi T; Muro Y; Akiyama M
    Br J Dermatol; 2018 Aug; 179(2):509-511. PubMed ID: 29603717
    [No Abstract]   [Full Text] [Related]  

  • 35. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.
    Liu G; Ma X; Wang Z; Wakae K; Yuan Y; He Z; Yoshiyama H; Iizasa H; Zhang H; Matsuda M; Sugiyama R; Yuan Z; Muramatsu M; Li L
    J Biol Chem; 2019 Sep; 294(38):14043-14054. PubMed ID: 31366735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restricting retrotransposons: ADAR1 is another guardian of the human genome.
    Orecchini E; Frassinelli L; Michienzi A
    RNA Biol; 2017 Nov; 14(11):1485-1491. PubMed ID: 28640667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editing of glutamate receptor subunit B pre-mRNA by splice-site variants of interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1.
    Liu Y; Samuel CE
    J Biol Chem; 1999 Feb; 274(8):5070-7. PubMed ID: 9988754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine deaminases acting on RNA, RNA editing, and interferon action.
    George CX; Gan Z; Liu Y; Samuel CE
    J Interferon Cytokine Res; 2011 Jan; 31(1):99-117. PubMed ID: 21182352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of a variant in the 5' untranslated region of ADAR1 in dyschromatosis symmetrica hereditaria.
    Suganuma M; Kono M; Yamanaka M; Akiyama M
    Pigment Cell Melanoma Res; 2020 Jul; 33(4):591-600. PubMed ID: 31926050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mendelian disease caused by variants affecting recognition of Z-DNA and Z-RNA by the Zα domain of the double-stranded RNA editing enzyme ADAR.
    Herbert A
    Eur J Hum Genet; 2020 Jan; 28(1):114-117. PubMed ID: 31320745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.